XEROX HOLDINGS CORP (XRX) Stock Analyst Ratings
NASDAQ:XRX - Nasdaq - US98421M1062 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 50% to XRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.51. This target is 64.21% above the current price.
XRX was analyzed by 12 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about XRX.
In the last month the buy percentage rose by 7 points. So the trust of analysts is improving.
XRX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-30 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-10-30 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2024-10-21 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-08-14 | Loop Capital | Maintains | Hold -> Hold |
| 2024-06-28 | Citigroup | Initiate | Sell |
| 2024-04-24 | JP Morgan | Maintains | Underweight -> Underweight |
| 2024-01-26 | JP Morgan | Maintains | Underweight -> Underweight |
| 2023-10-25 | JP Morgan | Maintains | Underweight -> Underweight |
| 2023-10-25 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2023-07-26 | Credit Suisse | Maintains | Underperform -> Underperform |
| 2023-07-26 | Morgan Stanley | Reiterate | Underweight -> Underweight |
| 2023-04-26 | Morgan Stanley | Maintains | Underweight |
| 2022-10-26 | Citigroup | Maintains | Sell |
| 2022-10-18 | Credit Suisse | Maintains | Underperform |
| 2022-10-17 | Morgan Stanley | Maintains | Underweight |
| 2022-08-17 | Credit Suisse | Initiate | Underperform |
| 2022-07-27 | Morgan Stanley | Maintains | Underweight |
| 2022-07-14 | JP Morgan | Maintains | Underweight |
| 2022-04-22 | Morgan Stanley | Maintains | Underweight |
| 2022-04-22 | Citigroup | Maintains | Sell |
| 2021-09-23 | Morgan Stanley | Initiate | Underweight |